Press Release – New York, New York – June 8, 2021 - Sichenzia Ross Ference LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX), a clinical-stage biotechnology company …
Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in Nasdaq listing and $25 Million Public Offering
Press Release – New York, NY – February 26, 2021 – Sichenzia Ross Ference LLP today announced that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSXV: BCT), a clinical-stage …